✦ LIBER ✦
The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial
✍ Scribed by Chris Skedgel; Daniel Rayson; Tallal Younis
- Book ID
- 109078969
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 191 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.